Tags: Monoclonal AntibodiesCancerAntibody ResearchBispecific AntibodiesDLBCL Trials
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | ||
| 2 | Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia | Resources and Education for Operationalizing Bispecifics - about 1 month ago Dosing Frequency and Formulary Decisions for Bispecific Antibodies - about 2 months ago Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - about 2 months ago Current Landscape of Bispecific Therapies for RRMM - about 2 months ago | |
| 3 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | ||
| 4 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | FDA Approves Zanidatamab for Biliary Tract Cancer - 2 months ago Novel Monoclonal Antibody Reduces Bleeds in Hemophilia A and B - about 1 year ago Year in Review: Follicular Lymphoma - about 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago | |
| 5 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 6 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 7 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 3 months ago | |
| 8 | PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom | Oncimmune announces new contract with global pharma company - 5 months ago | |
| 9 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 11 months ago | |
| 10 | Elizabeth Short MedPage Today Editorial intern @medpagetoday. New York, New York |